Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 2
1 [ . . . . : . . . . ] 94
batch____ bits E-value N 100.0% 1:94 MSMLVVVTENVPPRLRGRLAIWLLEVRAGVYVGDVSAKIREMIWEQIAGLAEEGNVVMAWATNTETGFEFQTFGLNRRTPVDLDGLRLVSFLPV
1 UniRef50_D0WFC5 DNA polymerase III, alpha c... 138 6e-32 1 36.0% 3:91 1:88 --MVVITLEKCPLALRGDLTKWLQEISMGVYVGQVSARVRDRLWERVCKECKSGRATMVYSVRNEQRHDFRIHNT-TWEPIDFDGLKLMMR---
2 UniRef50_D2RB05 CRISPR-associated endoribon... 136 2e-31 1 36.7% 1:90 1:89 MPLTVITMTNCPLSLRGDLTKWMQEIASGVYVGNFNSRVREELWKRIEDSVGNGAVTMSFSSRNEIGYDFKTIHSH-REVVYSDGLPLVR----
3 UniRef50_C2BET5 3'-5' exonuclease and CRISP... 132 3e-30 1 37.1% 1:89 1:88 MPLTVITLKNSPPSLRGDLTKWMQEIATGVYVGNFNTKIRQELWERVVESVGSGEATMTYAYRNEIGYKFETHNSN-KIMIDFEGIPLV-----
4 UniRef50_C6SPJ4 DNA polymerase III alpha su... 130 1e-29 1 35.2% 1:91 1:90 MPLTVITVKNAPPSLRGDLTKWMQEIATGVYVGNFNTKVREQLWSRVKDSVSNGEATLSFAYRNEIGYCFDTMNA-QRKVVDFEGIPLVQL---
5 UniRef50_C2D7T6 3'-5' exonuclease and CRISP... 129 2e-29 1 33.3% 1:93 19:109 MPLTIITLSKCPRSLRGDLTKWMQEIDTGVYVGNLNSRIREKLWSRVSNCVGSGSATLSFVAQNEIGYDFCTINSARR-VVYLDGIPLI-FTP-
6 UniRef50_B8IZA9 CRISPR-associated protein C... 129 3e-29 1 53.8% 3:93 1:91 --MLVIVTEAVPQRLRGYLSRWLLEVRAGVYVGNYSVRVRQKLWEVVCQQVGDGNAVLAWTSCHESGFQFLTVGANCREQIDWDGLPLVAYTP-
7 UniRef50_Q03C57 3'-5' exonuclease and CRISP... 128 5e-29 1 40.4% 3:91 1:88 --MIVITLSKVPPSLRGVLTKWCQEVQTGVYVGRFSARIRDSLWERIQRDIGSGEATIVFNAKNELGYQFRTTRTD-REVVDYDGLPLLLR---
8 UniRef50_B6XT67 Putative uncharacterized pr... 127 1e-28 1 38.2% 3:91 1:88 --MVVIVLTACPVGLRGDLTRWLLEISPGVFVGHLDARVREKLWERIVELSKNGRAIMVYSARNEQHLAFKVHGA-EWSPTDCEGLELVKR---
9 UniRef50_A4XYT6 CRISPR-associated protein, ... 127 1e-28 1 74.2% 1:93 1:93 MSFLVVVTENVPPRLRGRMAIWLLEVRAGVYIGDVSKRTREMIWEQLSQGHEDGNVVMAWASNHESGYEFQTLGPNRRLPVEFDGLHLVAFHP-
10 UniRef50_P45956 Uncharacterized protein ygb... 124 6e-28 1 100.0% 1:94 1:94 MSMLVVVTENVPPRLRGRLAIWLLEVRAGVYVGDVSAKIREMIWEQIAGLAEEGNVVMAWATNTETGFEFQTFGLNRRTPVDLDGLRLVSFLPV
11 UniRef50_C9M2Y5 Putative uncharacterized pr... 124 7e-28 1 36.4% 3:90 1:87 --MIVITLTKVPQSLRGDLTKWCQEVQTGVYVGSFSARIRDLLWKRILLNIGRGEATLIYTTNNELGYDFKTTRKD-KQVVQFDGIPVMM----
12 UniRef50_C7MTL7 CRISPR-associated protein C... 124 1e-27 1 39.1% 1:92 1:93 MplVVISTTAVPDYVRGSLSRWLTEPAPGLYVGSISARVRDSLWEQVSAAVGEGAAVCVHPTDNEQRYVIKTAGERRRRVMDFDGLQLIAFR--
13 UniRef50_A8LZ00 CRISPR-associated protein C... 123 2e-27 1 42.4% 2:93 3:94 -SLVVLATTAVPDHLRGALSRWMIEVTPGMFVGTLSAKVRDELWNAASSVVGDGAAVLIHPDDTEQGFSLRTAGARRRRPVDFDGLTLVAMSP-
14 UniRef50_Q2JWC8 CRISPR-associated protein C... 122 2e-27 1 42.2% 3:92 1:90 --MVVFILENVPASLRGDLSRWLFEIKAGVFVGRVSALVREELWARVTSKIGDGSALMVYSTNSEQGFSARSIGDPSRQLVDIEGVLLVKTY--
15 UniRef50_C7QEM1 CRISPR-associated protein C... 122 3e-27 1 39.3% 3:91 1:88 --MTVIVLTLCPVGLRGLLTRWLLEISAGVFIGSPSARVRDLLWDEVTSHAGKGRALLAYTTDNEQGFAFRTH-DHAWHPVDHEGLTLIHR---
16 UniRef50_C3PF98 CRISPR-associated protein n... 122 3e-27 1 37.1% 3:91 1:88 --MIVLVVTACPAGLRGDLSKWLIELTPGVFVGRPSARIRDLLWERTVELCKDGRALLVYSAANEQGLEFKTHR-HHWQPTDFDGVTLMVR---
17 UniRef50_A8M407 CRISPR-associated protein C... 122 3e-27 1 36.0% 3:91 1:88 --MTVIILTACPEGLRGHLTQWLLEISAGVYVGHVNSRIRHRLWAKVVDMAGPGRALLVYQQPGEQRLSF-TVHDHHWEPVDHDGITLMRR---
18 UniRef50_Q0W581 Predicted CRISPR-associated... 120 2e-26 1 37.8% 2:91 3:92 -SFSVFIVESVSPSLRGELTRWMIEPKAGVFIGKLSGMVRNKLWGKIIKNIKKGGCTMAYSYNNEQGYKIESYGDTTRTIVDFEGLSLVMT---
19 UniRef50_Q1J363 CRISPR-associated protein C... 120 2e-26 1 40.2% 6:92 1:87 -----MTLEAVPESLRGELSRWLIEVQPGVYVGNASALVRDLLWEKAVSHTRRGRCTQVYRANNEQGFIIRTHGDPTRRVVSLDGYQLVAVR--
20 UniRef50_B1VIX7 CRISPR-associated protein n... 120 2e-26 1 36.4% 4:91 1:87 ---MVLIVTACPAGLRGDLTKWLMELAPGTFVGRPSARIRELLWDRTVELCKDGRALLVYSSNNEQGMEFRTHR-HDWEPTDFDGLKLMMR---
21 UniRef50_C8XAY1 CRISPR-associated protein C... 117 9e-26 1 36.0% 3:91 1:88 --MVVLMLTACPAGLRGHLTRWLMEIGPGVFVGRVSHRVRDLLWDRVLELAKDGRAVMVYPARNEQGLEYRVHRS-SWKPIDVDGLTLMLR---
22 UniRef50_C7MTM4 CRISPR-associated protein, ... 117 1e-25 1 37.1% 3:91 1:89 --MTVIVLIAAPEGLRGHLTRWMVEVHAGVFVGNPSRRVRDRLWELLATRIADGQAILVEPADNEQGWAVRTAGTDRWRPTDFDGLILSAR---
23 UniRef50_D1CAI7 CRISPR-associated protein C... 116 2e-25 1 40.9% 3:90 1:88 --MVVMILERVPRSLRGELTRWMLEPKAGVFVGTMSALVRDKLWEKACASMKGGAGMLIYSSNTEQGFVVRFWGNLGREVVDFDGLTLIR----
24 UniRef50_C2GEZ2 CRISPR-associated Cas2 fami... 115 5e-25 1 39.3% 3:91 2:91 --FLVITCSAVPDHLHGYLTRFLSEVDTGVYVGNVSRRVRNNLWTRCATAIKSGRLTMINRDPeeQGFAVNTLGSQRRTIIDMDGLLLAST---
25 UniRef50_D1CGD7 CRISPR-associated protein C... 113 2e-24 1 44.3% 3:90 1:95 --MTVIVVEKVPASVRGELTRWLLEPRTGVFVGRPSALVRDKLWELVCQRieMGGAVMIYTSDNEQGFEMRIFGDTSRDLVDFEGLWLVK----
26 UniRef50_C5V9N8 CRISPR-associated protein C... 106 2e-22 1 30.8% 3:93 2:93 --FAVISCTAIPDHVRGFLTRFFSEVSTGLYVGIVSPVVLDNLWARIDGTITMGSFTLVHSCHeeQGFNIRMTGPQSRPLFDMDGLLLTSRVP-
27 UniRef50_D1Y483 CRISPR-associated protein C... 104 1e-21 1 35.9% 1:92 1:99 MPMTVVITNNVPMKYRGFLASCMLELAPGVYSHpmSAGIRQRIWQVIEKWYNesSIMLIWSDSSRPGGqiECLGLPARIVLDCDGVLLSRLS--
28 UniRef50_Q6NEQ2 Putative uncharacterized pr... 104 1e-21 1 25.3% 3:93 2:93 --FAVLYLQAAPDHLLGYVTRFLTEADTSIYVGNVSKNVASNLWIRVTEAIKDAHATMIVSDNseQGFSIMTTGDSTLQVLDADGLSVLASRP-
29 UniRef50_C2KP51 CRISPR-associated Cas2 fami... 104 1e-21 1 27.9% 3:88 2:88 --FVILTATAVPEHLHGYLSRFLTEVNMGVYVGKITPRVADALWERCRKVGKEGSLTLVQSdrFEQGFSVRAYSPRQHRVRCFDGLWL------
30 UniRef50_C4ZJY4 CRISPR-associated protein C... 101 6e-21 1 32.6% 1:92 1:97 MPLVVIVTRDVADRFRGFLKSVMLEVAPAVYVSpmSKGVRDRTWNVLAEWhpRGSIVMVWRDNNegGVGLAHLGEPPRELVEMDGMWVARLR--
31 UniRef50_C9M9S0 CRISPR-associated protein C... 100 2e-20 1 40.0% 3:92 1:96 --MLVLITNQVPMRVRGFLAACLLEVAPGVYVHpiNAGVRERIweWSVEFSQEASVLALWPApsSGGINIRTIGIPQRTLIDYDGLVLSKLT--
32 UniRef50_B8JDP4 CRISPR-associated protein C... 95 8e-19 1 36.3% 1:91 1:96 MPMTVIVTRDVPDRFRGFLASVALEIAPGVYTApmTASVRERAweDWHQHARQGAVVMTWPDGAAPGGqvLVLGDAPRELWVADGLVLARR---
33 UniRef50_A7BA60 Putative uncharacterized pr... 95 8e-19 1 38.2% 24:91 1:67 -----------------------MEISPGVFVGTLSARVRERLWVIVTENMKTGRAVMVYRARNEQGLEFLTWGDP-WKPVDFDGLTLMMR---
34 UniRef50_D0MET9 CRISPR-associated protein C... 94 9e-19 1 30.8% 1:91 1:97 MAMTIAVTRNTPGRFRGFLASCMLEIAPGVYVApmPRDVRERVWQVLLSWapDGGVVLLWRNRKApgLDVRLLGWPKKELVEYEGVWLAWR---
35 UniRef50_Q0BRF5 Putative uncharacterized pr... 94 1e-18 1 32.6% 1:92 2:98 MPATLVITRDVEARYRGYLTSIMLELSAGVYLSplSSAVRERTWAVLSEWHSegAIVLAWPdkSPGGMAIRTLGDAPKEIVDADGVLLVRKS--
36 UniRef50_Q04QB3 Putative uncharacterized pr... 90 3e-17 1 32.3% 26:90 1:64 -------------------------MKPGVFVASINARVRDRIWKKISE-AWKSDAIMLFSSNSEQGYGIRSHGDPSREIMDFDGLLLMS----
37 UniRef50_B3ENI1 CRISPR-associated protein C... 89 4e-17 1 26.4% 3:89 1:88 --MVIVVANDIPPAVRGRMKLWFVEPRANVFVSGIKDSVAKKVIDYLHKHCPSESGLMVFKSCNepGYEIFGHGDTRKQLIELSGMQLV-----
38 UniRef50_B6IWM0 CRISPR-associated protein C... 82 6e-15 1 29.3% 3:84 1:87 --MIVICLSDTADRFHGFLRSVMLNVHPGVYVsdLDKGSRERIWdrWWEAEPRGMVLMIHRdrKSMDLDLRSLGAPKRTIVDYD----------
39 UniRef50_UPI00016983CD CRISPR-associated protein, ... 78 7e-14 1 28.2% 1:78 1:84 MPLVVIVTRDVKDRFRGFLASVMLEVAPTVYISpmNQGVRSRTWKVLSDWHnqRSAWSGSDANETGGVGIATLGSPPR----------------
40 UniRef50_D0Y915 Putative uncharacterized pr... 64 1e-09 1 31.4% 40:90 2:53 ---------------------------------------RDELWERAINKTKESGAIliWTDQNSQGFSSRQYGERERTFVDFEGLYLVK----
41 UniRef50_C0W6T7 Putative uncharacterized pr... 59 6e-08 1 24.5% 40:92 2:53 ---------------------------------------REHLWEMVQTYIGDGRALLIWSVRSEQRFAVASLG-HEREPIDIEGCTVMRSS--
42 UniRef50_A4WZ21 Putative uncharacterized pr... 54 2e-06 1 47.9% 45:92 24:71 --------------------------------------------AQVVNHTEEGDAAMVWKAPTDQRFDFATTGRNRRMPVDVDGLKFVSFF--
43 UniRef50_C1DSI2 Putative uncharacterized pr... 52 8e-06 1 58.3% 58:93 1:36 ---------------------------------------------------------MAWTSRHESGHEFQTQGANRRLPVEFDGLHLMAFHP-
consensus/100% ..................................................................th.........h................
consensus/90% ..........................t.sha.t......tp.hWt.h.t.h.tuthhhhh.stpp.thth..ht...h..hph-Gh.l.....
consensus/80% ..hhlhhhptss.th+G.lt.hh.E.tsGlalu..sthlRp.lWthh.p.htpGtshhhatspp-.Ghthtshs...hp.h-h-Gl.Lh....
consensus/70% ..hhVlhhptsP.tlRG.Lsphh.EltsGVaVuphsstlR-plWptlhphhtpGpshhsasspsEtGhphpohGs.p+p.lDhDGl.Lhhh.
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown